Why is Thyrocare Tech. falling/rising?

As of 10-Sep, Thyrocare Technologies Ltd is experiencing a decline in its stock price, currently at Rs 1,281.00, which reflects a decrease of Rs 19.0 or 1.46%. The stock has underperformed its sector by 2.98% today and has been on a consecutive fall for the last four days, resulting in a total decline of 4.9% during this period. Additionally, the stock's performance over the past week and month shows a decrease of 1.65% and 3.92%, respectively, while it has shown strong growth year-to-date with a return of 40.35%. Despite positive financial indicators such as a high return on equity (ROE) of 20.45% and consistent profit growth, the stock faces challenges including a high valuation and a significant percentage of promoter shares being pledged, which can exert downward pressure on the stock price. In the broader market context, the Sensex has shown a positive return of 1.06% over the past week and 1.96% over the past month, contrasting with Thyrocare's negative performance during the same periods. This divergence indicates that while the overall market is performing well, Thyrocare is struggling, likely due to its recent price declines and falling investor participation, as evidenced by a 72.27% drop in delivery volume compared to the five-day average. The company's long-term growth concerns, particularly in net sales and operating profit, combined with its premium valuation compared to peers, contribute to the stock's current downward trajectory.